TABLE 4.
EXAM 6 | MODEL 1 |
MODEL 2 |
MODEL 3 |
MODEL 4 |
MODEL 5 |
|||||||||||||||
Unadjusted | CAIDE–APOE-ε4 | Age, sex, race, education | Demographic + APOE-ε4 + CV | Model 4 + NT-proBNP | ||||||||||||||||
|
|
|
and other “traditional” risk factors |
|
||||||||||||||||
β | 95% CI | p | β | 95% CI | p | β | 95% CI | p | β | 95% CI | p | β | 95% CI | p | ||||||
CASI | ||||||||||||||||||||
PIP (7.01%) | −1.49 | −2.00 | −0.99 | <0.001 | −1.46 | −1.96 | −0.96 | <0.001 | −0.60 | −1.05 | −0.15 | 0.010 | −0.50 | −0.95 | −0.04 | 0.032 | −0.47 | −0.92 | −0.01 | 0.045 |
PNNSS (13.7%) | −1.53 | −2.05 | −1.01 | <0.001 | −1.43 | −1.93 | −0.92 | <0.001 | −0.68 | −1.15 | −0.21 | 0.005 | −0.61 | −1.07 | −0.14 | 0.010 | −0.57 | −1.03 | −0.10 | 0.018 |
PNNLS (12.6%) | 1.54 | 1.02 | 2.06 | <0.001 | 1.44 | 0.94 | 1.95 | <0.001 | 0.69 | 0.22 | 1.16 | 0.004 | 0.57 | 0.11 | 1.02 | 0.015 | 0.52 | 0.06 | 0.98 | 0.026 |
| ||||||||||||||||||||
DSC | ||||||||||||||||||||
| ||||||||||||||||||||
PIP (6.95%) | −4.28 | −5.37 | −3.19 | <0.001 | −4.21 | −5.29 | −3.13 | <0.001 | −1.37 | −2.29 | −0.44 | 0.004 | −1.17 | −2.17 | −0.18 | 0.021 | −1.16 | −2.15 | −0.16 | 0.023 |
PNNSS (13.7%) | −3.91 | −5.01 | −2.80 | <0.001 | −3.67 | −4.77 | −2.57 | <0.001 | −1.60 | −2.51 | −0.69 | 0.001 | −1.54 | −2.54 | −0.54 | 0.003 | −1.55 | −2.56 | −0.54 | 0.003 |
PNNLS (12.6%) | 3.97 | 2.86 | 5.08 | <0.001 | 3.75 | 2.65 | 4.86 | <0.001 | 1.59 | 0.68 | 2.51 | 0.001 | 1.46 | 0.47 | 2.45 | 0.004 | 1.47 | 0.48 | 2.47 | 0.004 |
| ||||||||||||||||||||
DS forward | ||||||||||||||||||||
| ||||||||||||||||||||
PIP (7.09%) | −0.29 | −0.44 | −0.13 | <0.001 | −0.26 | −0.42 | −0.11 | 0.001 | −0.16 | −0.31 | 0.00 | 0.049 | −0.15 | −0.31 | 0.02 | 0.084 | −0.16 | −0.32 | 0.01 | 0.064 |
PNNSS (13.7%) | −0.25 | −0.41 | −0.09 | 0.002 | −0.22 | −0.38 | −0.06 | 0.008 | −0.15 | −0.30 | 0.00 | 0.057 | −0.14 | −0.31 | 0.02 | 0.092 | −0.16 | −0.33 | 0.01 | 0.064 |
PNNLS (12.6%) | 0.26 | 0.10 | 0.42 | 0.002 | 0.23 | 0.07 | 0.39 | 0.006 | 0.15 | 0.00 | 0.31 | 0.051 | 0.14 | −0.02 | 0.31 | 0.092 | 0.16 | −0.01 | 0.32 | 0.062 |
| ||||||||||||||||||||
DS backward | ||||||||||||||||||||
| ||||||||||||||||||||
PIP (7.09%) | −0.30 | −0.43 | −0.17 | <0.001 | −0.28 | −0.40 | −0.15 | <0.001 | −0.14 | −0.26 | −0.01 | 0.037 | −0.16 | −0.30 | −0.03 | 0.019 | −0.16 | −0.29 | −0.02 | 0.024 |
PNNSS (13.7%) | −0.29 | −0.43 | −0.16 | <0.001 | −0.26 | −0.39 | −0.12 | <0.001 | −0.13 | −0.25 | −0.01 | 0.039 | −0.17 | −0.31 | −0.04 | 0.009 | −0.18 | −0.31 | −0.05 | 0.009 |
PNNLS (12.6%) | 0.30 | 0.16 | 0.43 | <0.001 | 0.26 | 0.13 | 0.40 | <0.001 | 0.13 | 0.01 | 0.26 | 0.030 | 0.17 | 0.04 | 0.30 | 0.010 | 0.17 | 0.04 | 0.30 | 0.010 |
Values presented are the standardized ß regression coefficients and 95% CIs. Model 1 was unadjusted. Model 2 was adjusted for the CAIDE–APOE-ε4 risk index. Model 3 was adjusted for age, race/ethnicity, sex, and level of education attained. Model 4 included the variables of Model 3 in addition to prevalent CV and AF events, CV risk factors (usage of anti-hypertensive and lipid lowering medications, systolic BP, diabetes mellitus status, total cholesterol, high-density lipoprotein cholesterol, pack-years of cigarette smoking), alcohol consumption, weekly amounts of moderate and vigorous physical activity, depression, usage of antidepressant medications, total gross family income ≥ $75,000 and mean HR. Model 5 included the variables of Model 4 and NT-proBNP. The value in parenthesis after each independent variable (PIP, PNNSS and PNNLS) is its SD. Statistically significant associations (p value < 0.05) are highlighted in bold. Borderline significant associations (0.05≤p value ≤0.1) are highlighted using bold, italicized and underlined fonts.
AF, atrial fibrillation; BP, blood pressure; CAIDE, Cardiovascular Risk Factors, Aging, and Incidence of Dementia; CASI, the Cognitive Abilities Screening Instrument score; CI, confidence interval; CV, cardiovascular; DS, digit span; DSC, digit symbol coding; HR, heart rate; HRF, heart rate fragmentation; PIP, percentage of inflection points; PNNLS, percentage of NN intervals in long (≥3) accelerative/decelerative segments; PNNSS, percentage of NN intervals in short (<3) accelerative/decelerative segments; NT-proBNP, N-terminal prohormone B-type natriuretic peptide.